Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haaber, A. B.
Right arrow Articles by Strandgaard, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haaber, A. B.
Right arrow Articles by Strandgaard, S.

Journal of the American Society of Nephrology, Vol 5, 1581-1584, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure

AB Haaber, I Eidemak, T Jensen, B Feldt-Rasmussen and S Strandgaard
Department of Nephrology, Herlev County Hospital, Denmark.

Cardiovascular risk factors and markers of endothelial cell function were studied in nondiabetic patients with mild to moderate chronic renal failure. The transcapillary escape rate of albumin and the plasma concentrations of von Willebrand factor, fibrinogen, and plasma lipids were measured in 29 nondiabetic patients (GFR of 25 (11-44) mL/min x 1.73 m2 (median and range)) and 14 normal subjects. The proportion of smokers was similar between the groups. In the patients, the plasma concentration of von Willebrand factor was elevated by 61% (1.27 +/- 0.44 versus 0.79 +/- 0.28 U/mL; P < 0.01) (mean +/- SD) and that of fibrinogen was elevated by 72% (10.18 +/- 4.14 versus 5.92 +/- 2.01 mumol/L; P < 0.01). The plasma concentrations of lipoproteins showed an atherogenic pattern in the patients with increased levels of very low- density lipoprotein cholesterol (0.57 +/- 0.31 versus 0.33 +/- 0.13 mmol/L; P < 0.01) and triglycerides (1.26 +/- 0.25 versus 0.71 +/- 0.28 mmol/L; P < 0.01), but a decreased level of high-density lipoprotein cholesterol (1.23 +/- 0.33 versus 1.46 +/- 0.35 mmol/L; P < 0.05). Total cholesterol and low-density lipoprotein cholesterol were similar in the groups. The observed differences were further aggravated among smoking patients, particularly with respect to von Willebrand factor and triglycerides. The transcapillary escape rate of albumin was similar in the patients and the controls and was not correlated to the level of albuminuria.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
R. Vanholder, U. Baurmeister, P. Brunet, G. Cohen, G. Glorieux, J. Jankowski, and for the European Uremic Toxin Work Group
A Bench to Bedside View of Uremic Toxins
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
F. Kushiya, H. Wada, M. Sakakura, Y. Mori, E. C. Gabazza, M. Nishikawa, T. Nobori, M. Noguchi, K. Izumi, T. Nakasaki, et al.
Effects of Lipid Abnormalities on Arteriosclerosis and Hemostatic Markers in Patients under Hemodialysis
Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 203 - 210.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
G. M. London, S. J. Marchais, A. P. Guerin, F. Metivier, and H. Adda
Arterial structure and function in end-stage renal disease
Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1713 - 1724.
[Full Text] [PDF]


Home page
Vasc MedHome page
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani
Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease
Vascular Medicine, November 1, 2001; 6(4): 257 - 264.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. SEGARRA, P. CHACÓN, C. MARTINEZ-EYARRE, X. ARGELAGUER, J. VILA, P. RUIZ, J. FORT, J. BARTOLOMÉ, J. CAMPS, E. MOLINER, et al.
Circulating Levels of Plasminogen Activator Inhibitor Type-1, Tissue Plasminogen Activator, and Thrombomodulin in Hemodialysis Patients: Biochemical Correlations and Role as Independent Predictors of Coronary Artery Stenosis
J. Am. Soc. Nephrol., June 1, 2001; 12(6): 1255 - 1263.
[Abstract] [Full Text]


Home page
HeartHome page
J Thambyrajah, M J Landray, F J McGlynn, H J Jones, D C Wheeler, and J N Townend
Abnormalities of endothelial function in patients with predialysis renal failure
Heart, February 1, 2000; 83(2): 205 - 209.
[Abstract] [Full Text]


Home page
Nephrol Dial TransplantHome page
G. Cianciolo, S. Stefoni, F. Zanchelli, S. Iannelli, L. Coli, L. C. Borgnino, L. B. De Sanctis, V. Stefoni, A. De Pascalis, E. Isola, et al.
PDGF-AB release during and after haemodialysis procedure
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2413 - 2419.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Kunz, P. Petitjean, M. Lisri, F. Chantrel, C. Koehl, M.-L. Wiesel, J.-P. Cazenave, B. Moulin, and T. P. Hannedouche
Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1934 - 1942.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Kennon, A. Suliman, P. K. MacCallum, K. Ranjadayalan, P. Wilkinson, and A. D. Timmis
Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes
J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2018 - 2022.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP